Excessive compensation can attract primarily profit-seeking participants
Aliases: professional participants · profit-motivated participation · excessive incentive
What it is
When compensation is unusually high relative to burden, recruitment may disproportionately attract people who participate frequently for income. Wanting payment is not itself a defect—compensation is legitimate. The concern arises when motivation interacts with eligibility misrepresentation, concealed study experience, or repeated participation to alter the sample and responses.
Why it happens
High returns increase the payoff for guessing screeners, hiding recent participation, and searching for study cues. Experienced participants may infer hypotheses, use expected vocabulary, or complete tasks through familiarity. Multiple identities or platforms can also violate independence. Risk depends on more than amount: scarcity and how easily eligibility criteria can be inferred matter too.
Studying it
Audit implausibly fast screeners, inconsistent answers, duplicate devices or contacts, recent study frequency, and open-response quality without treating any single signal as proof. Compare channels or ethically reasonable payment bands on eligibility, duplication, attention, and composition. Predefine exclusions and manually review borderline cases.
Where it stops holding
High pay does not automatically imply undue influence or poor data. Scarce experts, high time costs, and expensive locations may justify greater compensation, and experienced participants can contribute carefully. Risk acceptability must be reviewed independently; payment cannot make otherwise unacceptable risk worthwhile. In its 2018 information sheet for FDA-regulated research in the United States, FDA treats participation payment as a recruitment incentive rather than a benefit in risk–benefit assessment and directs IRBs to review amount, method, and timing for coercion or undue influence. Other jurisdictions require their own rules. Aggressive identity checks also create privacy risks and exclude shared-device users.
Applying it
Establish acceptable risk first, then distinguish reimbursement of expenses from compensation for time, inconvenience, and scarce expertise; payment does not offset risk. Hide unnecessary screening cues and restrict repeat participation only when it creates practice effects, dependence, or hypothesis exposure. Do not exclude planned longitudinal follow-up. Combine consistency checks with appeal, and manage fraud, data quality, and fair payment as separate obligations.
Related
- Same group: Q1.12.1 Low compensation and participation bias · Q1.12.3 Reward format and sample composition · Q1.12.4 Performance-contingent payment
- Adjacent: Q1.11 Participant recruitment and screening · Q1.13 Informed consent and research ethics
- Search terms:
professional participants·fraud detection·undue influence